Our top pick for
SLR Investment Corp is an asset management business based in the US. SLR Investment shares (SLRC) are listed on the NASDAQ and all prices are listed in US Dollars.
|Latest market close||$19.83|
|52-week range||$14.11 - $20.05|
|50-day moving average||$19.42|
|200-day moving average||$19.00|
|Wall St. target price||$20.07|
|Dividend yield||$1.64 (8.25%)|
|Earnings per share (TTM)||$1.82|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-19)||0.30%|
|1 month (2021-09-24)||4.15%|
|3 months (2021-07-26)||4.53%|
|6 months (2021-04-26)||7.83%|
|1 year (2020-10-26)||23.55%|
|2 years (2019-10-25)||-3.22%|
|3 years (2018-10-26)||20.28|
|5 years (2016-10-26)||20.1|
Valuing SLR Investment stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of SLR Investment's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
SLR Investment's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 11x. In other words, SLR Investment shares trade at around 11x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
SLR Investment's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.65. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into SLR Investment's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$131.7 million|
|Operating margin TTM||66.84%|
|Gross profit TTM||$121.7 million|
|Return on assets TTM||2.8%|
|Return on equity TTM||9.02%|
|Market capitalisation||$840.6 million|
TTM: trailing 12 months
There are currently 254,895 SLR Investment shares held short by investors – that's known as SLR Investment's "short interest". This figure is 1% up from 252,377 last month.
There are a few different ways that this level of interest in shorting SLR Investment shares can be evaluated.
SLR Investment's "short interest ratio" (SIR) is the quantity of SLR Investment shares currently shorted divided by the average quantity of SLR Investment shares traded daily (recently around 194576.33587786). SLR Investment's SIR currently stands at 1.31. In other words for every 100,000 SLR Investment shares traded daily on the market, roughly 1310 shares are currently held short.
However SLR Investment's short interest can also be evaluated against the total number of SLR Investment shares, or, against the total number of tradable SLR Investment shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case SLR Investment's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 SLR Investment shares in existence, roughly 10 shares are currently held short) or 0.0073% of the tradable shares (for every 100,000 tradable SLR Investment shares, roughly 7 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against SLR Investment.
Find out more about how you can short SLR Investment stock.
Dividend payout ratio: 1.15% of net profits
Recently SLR Investment has paid out, on average, around 1.15% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 8.25% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), SLR Investment shareholders could enjoy a 8.25% return on their shares, in the form of dividend payments. In SLR Investment's case, that would currently equate to about $1.64 per share.
While SLR Investment's payout ratio might seem low, this can signify that SLR Investment is investing more in its future growth.
SLR Investment's most recent dividend payout was on 4 January 2021. The latest dividend was paid out to all shareholders who bought their shares by 21 September 2021 (the "ex-dividend date").
Over the last 12 months, SLR Investment's shares have ranged in value from as little as $14.1081 up to $20.05. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while SLR Investment's is 1.2804. This would suggest that SLR Investment's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Solar Capital Ltd. is a business development company specializing in secured debt (first lien unitranche and second lien), subordinated (unsecured) debt, minority equity, and strategic income-oriented control equity investments in leveraged middle market companies. The fund invests in aerospace and defense; air freight & logistics; asset management; automotive; banking; beverage, food and tobacco; building products; buildings and real estate; broadcasting and entertainment; cargo transport; commercial services and supplies; communications equipment; chemicals, plastics and rubber; containers, packaging and glass; construction & engineering; diversified/conglomerate manufacturing; consumer Finance; distributors; diversified/conglomerate services; diversified financial services; diversified real estate sctivities; food products; Footwear; Education Services; diversified telecommunications services; electronics; farming and agriculture; finance; grocery; health care equipment and supplies; health care facilities; education and childcare; home and office furnishing, durable consumer products; hotels, motels, inns and gaming; insurance; restaurants, leisure, amusement, and entertainment; leisure equipment tolls and services, media, multiline retail, multi sector holdings; paper and forest products; personal products; professional services, research and consulting services, software; specialty retail; textiles apparel and luxury goods, thrifts and mortgage finance, trading companies and distributors, utilities, and wireless telecommunication services; industrial conglomerates; internet software and services, IT services, machinery; mining, steel, iron, and non precious metals; oil and gas; personal, food and miscellaneous services; printing and publishing; retail stores; telecommunications; textiles and leather; and utilities. It also invests in life sciences with focus on specialty pharmaceuticals, medical devices, biotech, health Care Providers and services; health Care technology, enabling technologies and tools. Th.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.